熱門資訊> 正文
Nanox新成像系统Nanox获得FDA批准。ARC X
2025-04-17 22:49
- Nano-X Imaging (NASDAQ:NNOX) said on Thursday that it received clearance from the U.S. FDA for the Nanox.ARC X, its digital tomosynthesis device.
- The Nanox.ARC X system is used to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indications.
- Nanox will offer the Nanox.ARC X system, later this year, alongside the current Nanox.ARC, the company said.
More on Nano-X Imaging
- Nano-X Imaging Ltd. (NNOX) Q4 2024 Earnings Call Transcript
- Nano-X Imaging: When Will The Hockey Stick Growth Happen?
- Biggest stock movers Monday: COOP, HSMT, CYRX, PCVX, MRNA, NNOX and more
- SoundHound AI, Serve, Nano-X in focus as Nvidia exits stakes; cuts Arm investment
- Seeking Alpha’s Quant Rating on Nano-X Imaging
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
